HER2 Support Group Forums - View Single Post - Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockad

News · 06-03-2020, 07:09 PM

Volume 11, Issue 22 of Oncotarget reported that despite relevant medical advancements, metastatic breast cancer remains an incurable disease.

More...

06-03-2020, 07:09 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,951	Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockad Volume 11, Issue 22 of Oncotarget reported that despite relevant medical advancements, metastatic breast cancer remains an incurable disease. More...